Characterization of mutations in the VP1 region of Sabin strain type 1 polioviruses isolated from vaccine-associated paralytic poliomyelitis cases in Iran

Journal of Clinical Virology

Volumn 39, Issue 4, 2007, Pages 304-307

  Rahimi, Pooneh ^a   Tabatabaie, H ^a   Gouya, Mohammad M ^b   Zahraie, Mohsen ^b   Mahmudi, M ^a   Ziaie, A ^c   Rad, K Samimi ^a   Shahmahmudi, Sh ^a   Musavi, T ^b   Azad, T Mokhtari ^a   Nategh, R ^a  

^a Polio National Laboratory   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Acute flaccid paralysis; Vaccine associated paralytic poliomyelitis; Vaccine like poliovirus

Indexed keywords

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; ERADICATION THERAPY; FLACCID PARALYSIS; GENE MUTATION; GENETIC STABILITY; HUMAN; IMMUNIZATION; IRAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARALYSIS; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; STRAIN IDENTIFICATION; VIRUS ISOLATION; VIRUS MUTATION; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ADULT; AMINO ACID SUBSTITUTION; CAPSID PROTEINS; FEMALE; HUMANS; IRAN; MALE; MIDDLE AGED; MUSCLE HYPOTONIA; MUTATION; PARALYSIS; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, ORAL;

EID: 34447500287     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.04.017     Document Type: Article

References (20)

1. Belnap D.M., McDermott Jr. B.M., Filman D.J., Cheng N., Trus B.L., Zuccola H.J., et al. Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci 97 (2000) 73-78
2. Bouchard M.J., lam D.H., and Racaniello V.R. Determinats of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol 69 (1995) 4972-4978
3. Christodoulou C., and Horaud F. Mapping of mutations associated with neurovirolence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol 64 (1990) 4922-49299
4. Dowdle W.R., De Gourville E., Kew O.M., Pallansch M.A., and Wood D.J. Polio eradication: the OPV paradox. Rev Med Virol 13 (2003) 277-291
5. Esteves K. Safety of oral poliomyelitis vaccine results of WHO enquiry. Bull WHO 66 (1998) 739-746
6. Fine P.E.M., and Carneiro I.A.M. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol 150 (1999) 1001-1021
7. Georgescu M.M., Balanant J., Macadam A., Otelea D., Combiescu M., Combiescu A.A., et al. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis. J Virol 71 (1997) 7758-7768
8. Govrilin G.V., Cherkasova E.A., Lipskaya G.Y., Kew O.M., and Agol V.I. Evolution of circulating wild poliovirus and of vaccine derived poliovirus in an immunodeficient patient: a unifying model. J Virol 74 (2000) 7381-7390
9. Hiroyuki S., Thorley B., Paladin F.J., Brussen K.A., Stambos V., Yuen L., et al. Circulation of type1vaccine-derived poliovirus in the Philippines in 2001. J Virol 78 (2004) 13512-13521
10. Kew O.M., and Nottay B.K. Molecular epidemiology of polioviruses. Rev Infect Dis 6 Suppl. 2 (1984) 499-504
11. Kew O.M., Sufter R.W., Notay B.K., MeDonough M.J.K., Prevots D.R., Qick L., et al. Prolonged replication of a type 1 vaccine derived poliovirus in an immunodeficient patient. J Clin Microbiol 36 (1998) 2893-2899
12. Kew O.M., Sutter R.W., De Gourville E.M., Dowdle W.R., and Pallansch M.A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59 (2005) 587-635
13. Li J., Zhang L.B., Yoneyama T., Yoshida H., Shimizu H., Yoshii K., et al. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients. Arch Virol 141 (1996) 1047-1054
14. Martin J., and Minor P.D. characterization of CHAT and COX type live-attenuated poliovirus vaccine strains. J Virol 76 (2002) 5339-5349
15. MMWR, Dec 14, 2001.
16. Pallansch M.A., and Roos R.P. Enteroviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields's Virology vol. 1 (2000), Lippinco-Raven, Philadelphia, New York pp. 723-777
17. Wimmer E., Hellen C., and Cao X. Genetic of poliovirus. Annu Rev Genet 27 (1993) 353-436
18. Wien M.W., Curry S., Filman D.J., and Hogle J.M. Structural studies of poliovirus mutants that overcome receptor defect. Nat Struct Biol 4 (1997) 666-674
19. WHO/Unicef. Review of national immunization coverage 1980-2005, Iran. Aug 2006; 1-8.
20. World Health Organization. Polio laboratory manual, 4th ed. World Health Organization, Geneva, Switzerland; 2004.